UB Paderborn / Katalog / Suche / in CDI

Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?

Annals of oncology, 2015-01, Vol.26 (1), p.217-221

2015

Volltextzugriff (PDF)

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical nutrition (Edinburgh, Scotland), 2016-09, Vol.35, p.S148-S149

2016

Volltextzugriff (PDF)

MRI‐based score to predict surgical difficulty in patients with rectal cancer

British journal of surgery, 2018-01, Vol.105 (1), p.140-146

2018

Volltextzugriff (PDF)

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Breast cancer research and treatment, 2014-03, Vol.110 (5), p.1148-1154

2014

Volltextzugriff (PDF)

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer

Annals of oncology, 2009-12, Vol.20 (12), p.1964-1970

2009

Volltextzugriff (PDF)

Predictive factors assessment of pathological response to neoadjuvant radiotherapy of soft tissue sarcomas

Cancer radiothérapie, 2023-12, Vol.27 (8), p.689-697

2023

Volltextzugriff (PDF)

Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

Annals of oncology, 2019-07, Vol.30, p.iv26-iv27

2019

Volltextzugriff (PDF)

Quantifying circulating cell-free DNA as clinical biomarker

Annals of oncology, 2018-10, Vol.29, p.viii50-viii50

2018

Volltextzugriff (PDF)

Results of surgical revisions for ureteral complications after renal transplantation

Progrès en urologie (Paris), 2019-09, Vol.29 (10), p.474-481

2019

Volltextzugriff (PDF)

PO-0768: Evaluation of RT practice for limb soft tissue sarcomas and its impact on prognosis and toxicity

Radiotherapy and oncology, 2016-04, Vol.119, p.S359-S360

2016

Volltextzugriff (PDF)

Volumetric Modulated Arc Therapy for Bilateral Breast Carcinoma: Dosimetric Analysis and Immediate Tolerance

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S864-S864

2014

Volltextzugriff (PDF)

A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer

Annals of oncology, 2007-12, Vol.18 (12), p.2000-2005

2007

Volltextzugriff (PDF)

EP-1323: Final results of the IMRT Montpellier pilot study for prostate cancer

Radiotherapy and oncology, 2014, Vol.111, p.S96-S96

2014

Volltextzugriff (PDF)

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer

The pharmacogenomics journal, 2011-12, Vol.11 (6), p.437-443

2011

Volltextzugriff (PDF)

Combined Chemoradiation Therapy With Gemcitabine and Cisplatinum for Organ Preservation in Muscle-invasive Bladder Cancer: Long-term Results of a Phase I Trial

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S419-S419

2012

Volltextzugriff (PDF)

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

The New England journal of medicine, 2018-08, Vol.379 (5), p.417-427

2018

Volltextzugriff (PDF)

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment

Clinics and research in hepatology and gastroenterology, 2011-01, Vol.35 (1), p.48-54

2011

Volltextzugriff (PDF)

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

British journal of cancer, 2005-06, Vol.92 (12), p.2114-2121

2005

Volltextzugriff (PDF)

5098 POSTER Prognostic Factors of Breast Cancer Brain Metastases

European journal of cancer (1990), 2011, Vol.47, p.S359-S359

2011

Volltextzugriff (PDF)

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

Cancer chemotherapy and pharmacology, 2012-03, Vol.69 (3), p.807-814

2012

Volltextzugriff (PDF)

Five-year change in statistical designs of phase II trials published in leading cancer journals

European journal of cancer (1990), 2004-05, Vol.40 (8), p.1244-1249

2004

Volltextzugriff (PDF)

Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?

Annals of oncology, 2015-01, Vol.26 (1), p.217

2015

Volltextzugriff (PDF)

Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients

Oncology reports, 2005-10, Vol.14 (4), p.1029

2005

Volltextzugriff (PDF)

6091 POSTER Final Results of a Multicentre Phase II Trial Assessing Sorafenib in Combination With Irinotecan as 2nd or Later-line Treatment in Metastatic Colorectal Cancer (mCRC) Patients With KRas Mutated Tumours (mt) (NEXIRI)

European journal of cancer (1990), 2011, Vol.47, p.S418-S418

2011

Volltextzugriff (PDF)

The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma

Endoscopy, 2007-04, Vol.39 (4), p.309-313

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

MRI‐based score to predict surgical difficulty in patients with rectal cancer

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer

Predictive factors assessment of pathological response to neoadjuvant radiotherapy of soft tissue sarcomas

Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

Quantifying circulating cell-free DNA as clinical biomarker

Results of surgical revisions for ureteral complications after renal transplantation

PO-0768: Evaluation of RT practice for limb soft tissue sarcomas and its impact on prognosis and toxicity

Volumetric Modulated Arc Therapy for Bilateral Breast Carcinoma: Dosimetric Analysis and Immediate Tolerance

EP-1323: Final results of the IMRT Montpellier pilot study for prostate cancer

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer

Combined Chemoradiation Therapy With Gemcitabine and Cisplatinum for Organ Preservation in Muscle-invasive Bladder Cancer: Long-term Results of a Phase I Trial

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

5098 POSTER Prognostic Factors of Breast Cancer Brain Metastases

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

Five-year change in statistical designs of phase II trials published in leading cancer journals

Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?

Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients

6091 POSTER Final Results of a Multicentre Phase II Trial Assessing Sorafenib in Combination With Irinotecan as 2nd or Later-line Treatment in Metastatic Colorectal Cancer (mCRC) Patients With KRas Mutated Tumours (mt) (NEXIRI)

The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma

Suchergebnisse filtern